Phil Ferneau

Investor type:
Locations:

Social media:

Past investments

  • Compass Therapeutics
  • Avitide
  • Vets First Choice
  • Adimab
  • Genextropy
  • GlycoFi
  • M2S
  • Direct Vet Marketing
  • Kairos Biologics
  • Avedro